308 results
Categories
Human Remove Human filter
-
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021solution for infusion in Germany and France. In most other … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022
PRAC, Last updated: 10/06/2022use of these medicines in Germany and in Denmark. In addition … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 October 2022
PRAC, Last updated: 28/10/2022amfepramone medicines in Germany and in Denmark. In addition … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 02/05/2022 to 05/05/2022, Last updated: 06/02/2023 -
List item
Committee for Advanced Therapies (CAT): 7-9 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/12/2022 to 09/12/2022, Last updated: 08/02/2023 -
List item
Committee for Advanced Therapies (CAT): 15-17 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 15/02/2023 to 17/02/2023, Last updated: 15/02/2023 -
List item
Committee for Advanced Therapies (CAT): 3-4 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2022 to 04/11/2022, Last updated: 21/12/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/03/2022 to 10/03/2022, Last updated: 22/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/02/2022 to 10/02/2022, Last updated: 07/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 November - 1 December 2022
European Medicines Agency, Amsterdam, the Netherlands, from 28/11/2022 to 01/12/2022, Last updated: 29/11/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 November-2 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 29/11/2021 to 02/12/2021, Last updated: 04/10/2022 -
List item
Committee for Advanced Therapies (CAT): 5-7 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 05/10/2022 to 07/10/2022, Last updated: 05/10/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29 August - 1 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 29/08/2022 to 01/09/2022, Last updated: 02/09/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 25-28 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 25/10/2021 to 28/10/2021, Last updated: 02/08/2022 -
List item
Committee for Advanced Therapies (CAT): 15-17 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2022 to 17/06/2022, Last updated: 22/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 September 2022
European Medicines Agency, Amsterdam, the Netherlands, from 26/09/2022 to 29/09/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 24-27 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/10/2022 to 27/10/2022, Last updated: 04/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2022 to 10/06/2022, Last updated: 07/06/2022 -
List item
Committee for Advanced Therapies (CAT): 3-5 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2021 to 05/11/2021, Last updated: 31/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 04/07/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Advanced Therapies (CAT): 14-16 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 14/07/2021 to 16/07/2021, Last updated: 29/11/2021 -
List item
Committee for Advanced Therapies (CAT): 16-18 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 16/06/2021 to 18/06/2021, Last updated: 29/11/2021